Drugs / CBN
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04992962 | Jul → Oct 2021 | osteoarthritis, knee | Pure Green | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04992962 ↗ |
| Route | Other | “A water-soluble sublingual tablet containing 10 mg of CBD and 10 mg of CBN.” NCT04992962 ↗ |